Carlsmed, Inc. CARL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 56.75% | 58.17% | 61.19% | 98.39% | 98.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 56.75% | 58.17% | 61.19% | 98.39% | 98.70% |
| Cost of Revenue | 36.84% | 44.58% | 49.20% | 75.61% | 111.59% |
| Gross Profit | 63.96% | 62.72% | 65.26% | 106.90% | 94.41% |
| SG&A Expenses | 74.28% | 61.91% | 79.90% | 69.99% | 62.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 61.29% | 59.62% | 73.58% | 53.89% | 49.88% |
| Operating Income | -69.73% | -62.20% | -98.38% | -16.18% | -2.90% |
| Income Before Tax | -55.34% | -51.79% | -82.48% | -9.13% | -7.79% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -55.34% | -51.79% | -82.48% | -9.13% | -7.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.34% | -51.79% | -82.48% | -9.13% | -7.79% |
| EBIT | -69.73% | -62.20% | -98.38% | -16.18% | -2.90% |
| EBITDA | -69.32% | -61.60% | -97.85% | -15.61% | -2.50% |
| EPS Basic | 73.78% | 77.93% | 71.69% | 80.33% | 4.81% |
| Normalized Basic EPS | 73.78% | 75.68% | 71.68% | 78.83% | 4.80% |
| EPS Diluted | 73.78% | 77.93% | 71.69% | 80.33% | 4.81% |
| Normalized Diluted EPS | 73.78% | 75.68% | 71.68% | 78.83% | 4.80% |
| Average Basic Shares Outstanding | 492.43% | 524.16% | 544.47% | 415.61% | 13.24% |
| Average Diluted Shares Outstanding | 492.43% | 524.16% | 544.47% | 415.61% | 13.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |